The forecast for the import of blood-grouping reagents to Canada from 2024 to 2028 shows a consistent year-on-year decrease. The value is expected to decline from $13.898 million in 2024 to $13.305 million in 2028. This marks an average annual decrease, indicating a stable but contracting market trend over the five-year period.
Key variations include:
- A gradual decline in import values each year.
- An average annual contraction in market size.
Future trends to watch include advancements in medical technology and changes in healthcare policies, which may influence import demands. Additionally, monitor any international trade agreements that might impact cost or availability.
